1. Home
  2. AVTR vs GPCR Comparison

AVTR vs GPCR Comparison

Compare AVTR & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avantor Inc.

AVTR

Avantor Inc.

HOLD

Current Price

$11.23

Market Cap

7.8B

Sector

Industrials

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$75.44

Market Cap

6.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVTR
GPCR
Founded
1904
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
6.3B
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
AVTR
GPCR
Price
$11.23
$75.44
Analyst Decision
Hold
Strong Buy
Analyst Count
14
12
Target Price
$13.79
$103.09
AVG Volume (30 Days)
12.2M
1.3M
Earning Date
02-11-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,575,200,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.62
$13.22
52 Week High
$22.44
$94.90

Technical Indicators

Market Signals
Indicator
AVTR
GPCR
Relative Strength Index (RSI) 43.79 43.82
Support Level $10.67 $72.10
Resistance Level $11.34 $92.06
Average True Range (ATR) 0.38 4.50
MACD -0.10 -2.82
Stochastic Oscillator 22.55 9.96

Price Performance

Historical Comparison
AVTR
GPCR

About AVTR Avantor Inc.

Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: